ArticleFrontiers in medicine2025
A new approach to assessing pterygium progression and volume using SII and anterior segment OCT.
Article in Frontiers in medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Anterior Segment Optical Coherence Tomography with Angiography for the Cornea and Ocular Surface.Journal of clinical medicine · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: To compare the clinical manifestations and prognosis of 90 patients with pterygium. The occurrence and progression of pterygium are associated with the systemic immune-inflammatory index (SII) and clinical characteristics. The size of pterygium was assessed by anterior segment phase and anterior segment optical coherence tomography (AS-OCT). Methods: According to the pterygium score, the patients were divided into group A, group B, and group C. The evaluation parameters included gender, age, onset time, signs and symptoms of underlying diseases, AS-OCT, Neutrophil-to-Lymphocyte Ratio (NLR), Platelet-to-Lymphocyte Ratio (PLR), Monocyte-to-Lymphocyte Ratio (MLR), and SII values. The postoperative pterygium tissue was weighed. The clinical characteristics of each group were analysed by a nonparametric test and a chi-square test. Ordered logistic regression analysis evaluated the parameters related to pterygium area and volume. Results: Compared with the control group, the SII, NLR, and MLR values of pterygium patients were significantly increased. The incidence of both eyes in group C was significantly higher than that in groups A and B. The incidence of both eyes and the SII value would affect the severity of pterygium. The SII value was significantly correlated with the area of pterygium progression and weighing volume. The combination of the anterior segment phase and AS-OCT can effectively evaluate the volume of pterygium. Conclusion: SII can be used as a biomarker to predict the severity and prognosis of pterygium. Compared with traditional methods, imaging data can better evaluate the progression of pterygium by calculating the volume of pterygium.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.